Skip to main content
×
Home
    • Aa
    • Aa

Hearing status in patients with rheumatoid arthritis

  • A Ahmadzadeh (a1), M Daraei (a1), M Jalessi (a2), A A Peyvandi (a3), E Amini (a2) (a4), L A Ranjbar (a1) and A Daneshi (a4)...
Abstract
Abstract Objective:

Rheumatoid arthritis is thought to induce conductive hearing loss and/or sensorineural hearing loss. This study evaluated the function of the middle ear and cochlea, and the related factors.

Methods:

Pure tone audiometry, speech reception thresholds, speech discrimination scores, tympanometry, acoustic reflexes, and distortion product otoacoustic emissions were assessed in rheumatoid arthritis patients and healthy volunteers.

Results:

Pure tone audiometry results revealed a higher bone conduction threshold in the rheumatoid arthritis group, but there was no significant difference when evaluated according to the sensorineural hearing loss definition. Distortion product otoacoustic emissions related prevalence of conductive or mixed hearing loss, tympanometry values, acoustic reflexes, and speech discrimination scores were not significantly different between the two groups. Sensorineural hearing loss was significantly more prevalent in patients who used azathioprine, cyclosporine and etanercept.

Conclusion:

Higher bone conduction thresholds in some frequencies were detected in rheumatoid arthritis patients that were not clinically significant. Sensorineural hearing loss is significantly more prevalent in refractory rheumatoid arthritis patients.

Copyright
Corresponding author
Address for correspondence: Dr Elahe Amini, Skull Base Research Center, ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Niayesh St, Sattar Khan Ave, Tehran, Iran Fax: +98 216 652 5329 E-mail: elaheaminimd@gmail.com
References
Hide All
1 AlamanosY, DrososAA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005;4:130–6
2 MuellerRB, SchiffM, KaegiT, FinckhA, HaileSR, Schulze-KoopsH et al. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis. Clin Rheumatol 2015;34:51–9
3 TuressonC, O'FallonW, CrowsonC, GabrielS, MattesonE. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722–7
4 CopemanWS. Rheumatoid oto-arthritis. Br Med J 1963;2:1526–7
5 RosenbergJN, MoffatDA, RamsdenRT, GibsonWP, BoothJB. Middle ear function in rheumatoid arthritis. Ann Rheum Dis 1978;37:522–4
6 OzcanM, KarakusMF, GunduzOH, TuncelU, SahinH. Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int 2002;22:1619
7 OzturkA, YalcinS, KaygusuzI, SahinS, GokU, KarlidagT et al. High-frequency hearing loss and middle ear involvement in rheumatoid arthritis. Am J Otolaryngol 2004;25:411–17
8 GoodwillCJ, LordIJ, JonesRP. Hearing in rheumatoid arthritis. A clinical and audiometric survey. Ann Rheum Dis 1972;31:170–3
9 American Speech-Language-Hearing Association Committee on Audiometric Evaluation. Guidelines for manual pure-tone threshold audiometry. ASHA 1978;20:297301
10 MathersC, SmithA, ConchaM. Global Burden of Hearing Loss in the Year 2000. Global Burden of Disease. Geneva: World Health Organization, 2003;130
11 Siamopoulou-MavridouA, AsimakopoulosD, MavridisA, SkevasA, MoutsopoulosHM. Middle ear function in patients with juvenile chronic arthritis. Ann Rheum Dis 1990;49:620–3
12 Campos UdeP, CarvalloRM. Correlation between DPOAE I/O functions and pure-tone thresholds. Braz J Otorhinolaryngol 2011;77:754–60
13 DikiciO, MulukNB, TosunAK, UnlusoyI. Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels. Eur Arch Otorhinolaryngol 2009;266:1719–26
14 MurdinL, PatelS, WalmsleyJ, YeohLH. Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol 2008;27:637–40
15 SimopoulosA. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006;60:502–7
16 JamshidiAR, Tehrani BanihashemiA, RoknsharifiS, AkhlaghiM, SalimzadehA, DavatchiF. Estimating the prevalence and disease characteristics of rheumatoid arthritis in Tehran: a WHO -ILAR COPCORD Study (from Iran COPCORD study, Urban Study stage 1). Med J Islam Repub Iran 2014;28:93
17 AlishiriGH, SalimzadehA, OwliaMB, ForghanizadehJ, SetarehshenasR, ShayanfarN. Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics. BMC Musculoskelet Disord 2006;7:43
18 Trevino-GonzalezJL, Villegas-GonzalezMJ, Munoz-MaldonadoGE, Montero-CantuCA, Nava-ZavalaAH, Garza-ElizondoMA. Subclinical sensorineural hearing loss in female patients with rheumatoid arthritis [in Spanish]. Cir Cir 2015;83:364–70
19 OzkirisM, KapusuzZ, GunaydinI, KubilayU, PirtiI, SaydamL. Does rheumatoid arthritis have an effect on audiovestibular tests? Eur Arch Otorhinolaryngol 2014;271:1383–7
20 BortoliR, SantiagoM. Chloroquine ototoxicity. Clin Rheumatol 2007;26:1809–10
21 Pascual-RamosV, Contreras-YanezI, Rivera-HoyosP, EnriquezL, Ramirez-AnguianoJ. Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA). Clin Rheumatol 2014;33:315–21
22 GorgaM, NeelyS, BergmanB, BeauchaineK, KaminskiJ, PetersJ et al. Otoacoustic emissions from normal-hearing and hearing-impaired subjects: distortion product responses. J Acoust Soc Am 1993;93:2050–60
23 GorgaM, NeelyS, DarnP. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards. Ear Hear 1999;20:345–62
24 GorgaM, NelsonK, DavisT, DarnP, NeelyS. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-fl are used to predict auditory status. J Acoust Soc Am 2000;107:2128–35
25 NortonS, GorgaM, WidenJ, FolsomR, SiningerY, Cone-WessonB et al. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance. Ear Hear 2000;21:508–28
26 DagliM, Sivas AcarF, KarabulutH, EryilmazA, Erkol InalE. Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 2007;27:511–16
27 DrexlM, FaulstichM, von StebutB, Radtke-SchullerS, KösslM. Distortion product otoacoustic emissions and auditory evoked potentials in the hedgehog tenrec, Echinops telfairi. J Assoc Res Otolaryngol 2003;4:555–64
28 BrownAM, KempDT. Suppressibility of the 2fl−f2 stimulated acoustic emissions in gerbil and man. Hear Res 1984;13:2937
29 JenkinsonPW, SyedMI, McClymontL. Progressive, reversible sensorineural hearing loss caused by azathioprine. J Laryngol Otol 2014;128:838–40
30 WangX, TruongT, BillingsPB, HarrisJP, KeithleyEM. Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol 2003;24:52–7
31 McClellandL, PowellRJ, BirchallJ. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss. Acta Otolaryngol 2005;125:1356–60
32 FransenJ, Van RielP. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23(5 suppl 39):S93–9
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 2
Total number of PDF views: 27 *
Loading metrics...

Abstract views

Total abstract views: 168 *
Loading metrics...

* Views captured on Cambridge Core between 15th August 2017 - 21st October 2017. This data will be updated every 24 hours.